Accumulation of aggregated alpha-synuclein in neural tissue structures in neurodegenerative diseases

Accumulation of aggregated alpha-synuclein in neural tissue structures in neurodegenerative diseases

A critical analysis of the literature on the structure and properties of alpha-synuclein under physiological and pathological conditions is presented, when the conformation of this protein changes, which contributes to its aggregation and changes in localization features in brain structures in such...

Full description

Bibliographic Details
Main Authors:	V. N. Salkov, D. N. Voronkov
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2024-01-01
Series:	Acta Biomedica Scientifica
Subjects:	conformations of alpha-synuclein neurons neuroglia parkinson’s disease dementia with lewy bodies multiple system atrophy alzheimer’s disease
Online Access:	https://www.actabiomedica.ru/jour/article/view/4501

Similar Items

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
by: Naomi P. Visanji, et al.
Published: (2019-09-01)

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
by: Janett Köppen, et al.
Published: (2020-01-01)

Pyrroloquinoline quinone influences intracellular alpha-synuclein aggregates
by: Elizabeth Mountford, et al.
Published: (2023-01-01)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
by: Tian-Sin Fan, et al.
Published: (2021-11-01)

Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease
by: Desiree A. Piper, et al.
Published: (2018-04-01)

14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
by: Rachel Underwood, et al.
Published: (2021-01-01)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
by: P.G. Foulds, et al.
Published: (2012-01-01)

Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
by: Grace M. Lloyd, et al.
Published: (2023-07-01)

Alpha-Synuclein Pathology Coincides With Increased Number of Early Stage Neural Progenitors in the Adult Hippocampus
by: Hannah Bender, et al.
Published: (2021-07-01)

Alpha-synuclein aggresomes inhibit ciliogenesis and multiple functions of the centrosome
by: Anila Iqbal, et al.
Published: (2020-10-01)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
by: Hiroaki Sekiya, et al.
Published: (2022-09-01)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
by: David J. Koss, et al.
Published: (2022-07-01)

Calcium: alpha-synuclein interactions in alpha-synucleinopathies
by: Alexandre N. Rcom-H’cheo-Gauthier1, et al.
Published: (2016-12-01)

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice
by: Matthieu Lilamand, et al.
Published: (2022-11-01)

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
by: Anna Emdina, et al.
Published: (2022-05-01)

Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?
by: Arati Tripathi, et al.
Published: (2021-12-01)

Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
by: Allison J. Schaser, et al.
Published: (2020-08-01)

Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
by: Berkiye Sonustun, et al.
Published: (2022-03-01)

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
by: Kamil Saramowicz, et al.
Published: (2023-12-01)

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
by: Nelson de Oliveira Manzanza, et al.
Published: (2021-06-01)

Cell Culture Media, Unlike the Presence of Insulin, Affect α-Synuclein Aggregation in Dopaminergic Neurons
by: Irena Hlushchuk, et al.
Published: (2022-04-01)

Neuropathological evidence of body-first vs. brain-first Lewy body disease
by: Per Borghammer, et al.
Published: (2021-12-01)

Alpha Synuclein: Neurodegeneration and Inflammation
by: Gianluigi Forloni
Published: (2023-03-01)

Alpha-synuclein as a biomarker of Parkinson’s disease
by: S. N. Pchelina
Published: (2017-02-01)

Effects of α-synuclein on axonal transport
by: Laura A. Volpicelli-Daley
Published: (2017-09-01)

Kaempferol Has Potent Protective and Antifibrillogenic Effects for α-Synuclein Neurotoxicity In Vitro
by: Masatoshi Inden, et al.
Published: (2021-10-01)

Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders
by: Stefan Bräuer, et al.
Published: (2023-10-01)

Alpha-synuclein structure, functions, and interactions
by: Fatemeh Nouri Emamzadeh
Published: (2016-01-01)

Dementia with Lewy bodies: an update and outlook
by: Tiago Fleming Outeiro, et al.
Published: (2019-01-01)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
by: Ichiro Kawahata, et al.
Published: (2022-06-01)

Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity
by: Shamini Vijayakumaran, et al.
Published: (2015-07-01)

Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration
by: Xinhe Wang, et al.
Published: (2019-03-01)

The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
by: Nicole K. Polinski, et al.
Published: (2022-06-01)

β-Synuclein: An Enigmatic Protein with Diverse Functionality
by: Junna Hayashi, et al.
Published: (2022-01-01)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
by: Kathrin Brockmann, et al.
Published: (2020-09-01)

α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies
by: Noah J. Graves, et al.
Published: (2023-07-01)

Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor
by: Elizabeth Terry-Kantor, et al.
Published: (2020-07-01)

Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates
by: Resnikoff H, et al.
Published: (2019-05-01)

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF
by: Walter A. Boiten, et al.
Published: (2020-12-01)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
by: Rachel Kelly, et al.
Published: (2021-11-01)